Benchmark analyst Robert Wasserman initiated coverage of Kamada (KMDA) with a Buy rating and $15 price target
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMDA:
- Kamada Expands Plasma Collection Operations with New San Antonio Center
- Kamada opens third plasma collection center in San Antonio, Texas
- Kamada: A Growth-Oriented Investment with Strong Financials and Strategic Expansion Plans
- Kamada Ltd’s Growth at Risk: Manufacturing Capacity and Expansion Challenges Loom Large
- Kamada Ltd. Reports Record 2024 Financial Results